Target intelligence / Profile preview

Immunoglobulin heavy diversity 2-8 (IGHD2-8)

Target
IGHD2-8
Molecular classification
Immunoglobulin gene segment, Germline diversity segment (D-segment, part of V(D)J recombination), Other
01

Overview

Immunoglobulin heavy diversity 2-8 (IGHD2-8) is one of several diversity gene segments located within the immunoglobulin heavy chain (IGH) locus on chromosome 14q32. During B cell development, the immune system generates high antibody diversity by somatically recombining variable (V), diversity (D), and joining (J) gene segments to form unique antibody receptor sequences. IGHD2-8 acts as a germline D-segment—one of the building blocks incorporated into the heavy chain variable region through V(D)J recombination, which is essential for the adaptive immune system's ability to recognize a vast array of antigens. IGHD segments themselves do not encode functional receptors or proteins; instead, their encoded sequence contributes to the final structure of immunoglobulin proteins following recombination in B lymphocytes. Key insights for structure: - IGHD2-8 is a gene segment (not a protein, enzyme, receptor, or biomarker). - It plays a structural and genetic role in antibody diversity but is not a direct disease gene or drug target. - This entry is not suitable for typical "therapeutic target" mapping. Most drug/biomarker information is null. - The canonical name and abbreviation provided are recognized in immunogenetics databases. - Alternative names ("DLR1", "IGHD28") arise from historical and database synonym conventions.

Other names
IGHD28DLR1IGHD2-8
02

Biological functions

Generation of antibody diversity (via V(D)J recombination)Adaptive immune responseOther
03

Disease associations

Other

Beyond the preview

Go deeper on Immunoglobulin heavy diversity 2-8 (IGHD2-8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy diversity 2-8 (IGHD2-8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call